Global Retirement Partners’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-66
Closed -$17K 3116
2022
Q3
$17K Hold
66
﹤0.01% 1475
2022
Q2
$16K Buy
66
+5
+8% +$1.35K ﹤0.01% 1458
2022
Q1
$15K Buy
+61
New +$18.8K ﹤0.01% 1477
2019
Q4
Sell
-115
Closed -$20K 1730
2019
Q3
$20K Sell
115
-3
-3% -$648 ﹤0.01% 906
2019
Q2
$31K Buy
118
+3
+3% +$796 0.01% 746
2019
Q1
$33K Hold
115
0.01% 671
2018
Q4
$37K Buy
115
+15
+15% +$5.21K 0.01% 580
2018
Q3
$45K Hold
100
0.01% 592
2018
Q2
$41K Hold
100
0.01% 589
2018
Q1
$29K Sell
100
-28
-22% -$7.1K 0.01% 663
2017
Q4
$24K Buy
+128
New +$23.9K 0.01% 684

Other funds holding ABMD

Global Retirement Partners's ABMD Position: Q4 2022 in Review

Global Retirement Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 66 shares — an estimated $17K sold.

Global Retirement Partners first reported a position in ABMD in Q4 2017 and held it in 11 quarters. The position peaked at $45K in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Global Retirement Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Global Retirement Partners sold 66 Abiomed Inc shares in Q4 2022, an estimated $17K.
  • Global Retirement Partners first reported a position in Abiomed Inc in Q4 2017 and held it in 11 quarters.
  • Global Retirement Partners's Abiomed Inc position peaked at $45K in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Global Retirement Partners's 13F filing for Q4 2022, filed 13 Feb 2023.